Ischemic lesions are highly prevalent in patients with traumatic brain injuries (TBIs) and are the single most important cause of secondary brain damage. The prevention and early treatment of these lesions is the primary aim in the modern treatment of these patients. One of the most widely used monitoring techniques at the bedside is quantification of brain extracellular level of lactate by using arteriojugular venous differences of lactate (AVDL). The purpose of this study was to determine the sensitivity, specificity, and predictive value of AVDL as an indicator of increases in brain lactate production in patients with TBIs.
Arteriojugular venous differences of lactate were calculated every 6 hours using samples obtained though a catheter placed in the jugular bulb in 45 patients with diffuse head injuries (57.8%) or evacuated brain lesions (42.2%). Cerebral lactate concentration obtained with a 20-kD microdialysis catheter implanted in undamaged tissue was used as the de facto gold standard.
Six hundred seventy-three AVDL determinations and cerebral microdialysis samples were obtained simultaneously; 543 microdialysis samples (81%) showed lactate values greater than 2 mmol/L, but only 21 AVDL determinations (3.1%) showed an increase in brain lactate. No correlation was found between AVDL and cerebral lactate concentration (ρ = 0.014, p = 0.719). Arteriojugular venous differences of lactate had a sensitivity and specificity of 3.3 and 97.7%, respectively, with a false-negative rate of 96.7% and a false-positive rate of 2.3%.
Arteriojugular venous differences of lactate do not reliably reflect increased cerebral lactate production and consequently are not reliable in ruling out brain ischemia in patients with TBIs. The clinical use of this monitoring method in neurocritical care should be reconsidered.
Abbreviations used in this paper: AVDL = arteriojugular venous differences of lactate; AVDO2 = AVD of O2; BBB = blood–brain barrier; CBF = cerebral blood flow; CI = confidence interval; CT = computed tomography; GCS = Glasgow Coma Scale; ICP = intracranial pressure; ICU = intensive care unit; LOI = lactate-O2 index; SaO2 = arterial O2 saturation; SjO2 = jugular O2 saturation; TBI = traumatic brain injury.
Address reprint requests to: Juan Sahuquillo, M.D., Ph.D., Department of Neurosurgery, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. email:
Anonymous: The Brain Trauma Foundation. The American Association of Neurological Surgeons The Joint Section on Neurotrauma Critical Care Management and prognosis of severe traumatic brain injury Part 1: guidelines for the management of severe traumatic brain injury. J Neurotrauma17:457–6272000
BakkerEPvan DamK: The movement of monocarboxylic acids across phospholipid membranes: evidence for an exchange diffusion between pyruvate and other monocarboxylate ions. Biochim Biophys Acta339:285–2891974
HilleredLPerssonLMicrodialysis for neurochemical monitoring in the human brain injury. TsubokawaTMarmarouARobertsonCTeasdaleG: Neurochemical Monitoring in the Intensive Care Unit. Microdialysis Jugular Venous Oximetry and Near-Infrared SpectroscopyTokyoSpringer-Verlag1995. 59–63
MurrRStummerWSchurerLPolasekJ: Cerebral lactate production in relation to intracranial pressure, cranial computed tomography findings, and outcome in patients with severe head injury. Acta Neurochir (Wien)138:928–9371996
PocaMASahuquilloJVilaltaADe los RiosJRoblesAExpositoL: Percutaneous implantation of cerebral microdialysis catheters by twist-drill craniostomy in neurocritical patients: description of the technique and results of a feasibility study in 97 patients. J Neurotrauma23:1510–15172006
PriceNTJacksonVNHalestrapAP: Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem J329:321–3281998
ReinstrupPStahlNMellergardPUskiTUngerstedtUNordstromCH: Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery47:701–7102000
RobertsonCSAnaerobic metabolism within the brain: its relationship to brain failure in head-injuried patients. BihariDHoladayJW: Update in Intensive Care and Emergency Medicine 9. Brain FailureBerlinSpringer-Verlag1989. 85–102
SahuquilloJBiestroAMenaMPAmorosSLungMPocaMA: [First tier measures in the treatment of intracranial hypertension in the patient with severe craniocerebral trauma. Proposal and justification of a protocol.]. Neurocirugia13:78–1002002. (Spanish)
Sappey-MarinierDCalabreseGFeinGHuggJWBigginsCWeinerMW: Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab12:584–5921992
ToftengFLarsenFS: Monitoring extracellular concentrations of lactate, glutamate, and glycerol by in vivo microdialysis in the brain during liver transplantation in acute liver failure. Liver Transpl8:302–3052002
VespaPBergsneiderMHattoriTWuHMHuangSCMartinNA: Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab25:763–7742005
VespaPMMcArthurDO'PhelanKGlennTEtchepareMKellyD: Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab23:865–8772003
ZaunerADoppenbergEMWoodwardJJChoiSCYoungHFBullockR: Continuous monitoring of cerebral substrate delivery and clearance: initial experience in 24 patients with severe acute brain injuries. Neurosurgery41:1082–10931997